Cargando…
Antiviral treatment of COVID-19
Currently, there is not any specific effective antiviral treatment for COVID-19. Although most of the COVID-19 patients have mild or moderate courses, up to 5%–10% can have severe, potentially life threatening course, there is an urgent need for effective drugs. Optimized supportive care remains the...
Autores principales: | ŞİMŞEK YAVUZ, Serap, ÜNAL, Serhat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195979/ https://www.ncbi.nlm.nih.gov/pubmed/32293834 http://dx.doi.org/10.3906/sag-2004-145 |
Ejemplares similares
-
An update of anti-viral treatment of COVID-19
por: ŞİMŞEK YAVUZ, Serap, et al.
Publicado: (2021) -
Perioperative COVID-19 in cardiac surgery: A toxic coexistence
por: Şimşek-Yavuz, Serap
Publicado: (2022) -
Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment
por: Sahin, Gokben, et al.
Publicado: (2022) -
Investigation of antiviral substances in Covid 19 by Molecular Docking: In Silico Study
por: Oner, Erkan, et al.
Publicado: (2023) -
Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU
por: ÇALIK BAŞARAN, Nursel, et al.
Publicado: (2021)